ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cardiovascular disease"

  • Abstract Number: L01 • 2018 ACR/ARHP Annual Meeting

    New Cardiovascular Events in Patients with Gout Treated with Xanthine-Oxidase Inhibitors: An Inception Cohort Analysis

    Neus Quilis1, Laura Ranieri2, Jose Sanchez-Paya2 and Mariano Andrés2, 1Hospital Universitario del Vinalopó, Elche, Spain, 2Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain

    Background/Purpose: The recent CARES trial findings have contributed to the controversy around the development of cardiovascular (CV) events in gouty patients using febuxostat (FBX). In…
  • Abstract Number: L05 • 2018 ACR/ARHP Annual Meeting

    Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Reversible Abnormalities of Vascular Function on Cardiac MRI with RA Therapy with Preliminary Suggestion of Greater Improvement with Anti-TNF Compared to MTX/Conventional Therapy – a First, RCT Derived Longitudinal Study

    Maya H. Buch1, Bara Erhayiem2, Graham Fent2, Paul Baxter3, Elizabeth M.A. Hensor4, Adam McDiarmid2, Peter Swoboda5, Ananth Kidambi2, David Ripley2, Pankaj Garg2, Sarah Horton4, Raluca Bianca Dumitru4, Kamran Naraghi4, John Greenwood6, Paul Emery7, Sue Pavitt8 and Sven Plein2, 1Leeds Institute of Rheumatic & Musculosekeltal Medicine, University of Leeds & NIHR Biomedical Research Centre, Leeds, United Kingdom, 2Multidisciplinary Cardiovascular Research Centre, Leeds Institute of Cardiovascular & Metabolic Medicine, University of Leeds, Leeds, United Kingdom, 3Leeds Institute of Cardiovascular & Metabolic Medicine, University of Leeds, Leeds, United Kingdom, 4Leeds Institute of Rheumatic & Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 5Leeds Institute of Cardiovascular And Metabolic Medicine, University of Leeds, Leeds, United Kingdom, 6Leeds Institute of Cardiovascular And Metabolic Medicinee, University of Leeds, Leeds, United Kingdom, 7University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom, 8Leeds School of Dentistry, University of Leeds, Leeds, United Kingdom

    Background/Purpose: We previously reported abnormal cardiac MRI (CMR)-determined aortic stiffness in patients with early, treatment-naive RA1,2. We now report on whether this vascular stiffness is…
  • Abstract Number: 501 • 2018 ACR/ARHP Annual Meeting

    Predictors of Change in Coronary Plaque Burden and Composition in Patients with Rheumatoid Arthritis

    George Karpouzas1, Sarah Ormseth2, Elizabeth Hernandez2 and Matthew Budoff3, 1Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 2Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 3Cardiology, Harbor-UCLA Medical Center, Torrance, CA

    Background/Purpose: We previously reported higher prevalence, burden and more vulnerable occult coronary plaque composition in patients with rheumatoid arthritis (RA) compared to age and gender-matched…
  • Abstract Number: 752 • 2018 ACR/ARHP Annual Meeting

    Prevalence and Predictors of Peripheral Vascular Disease in a Cohort of Systemic Lupus Erythematosus (SLE) Patients

    Ida Dzifa Dey1, Kelvin Acquaye2, Alfred Yawson3, Kofi Agyabeng4, Ernest Yorke5, Vincent Boima6 and Charles Mate-Kole7, 1Department of Medicine, Rheumatology Unit, School of Medicine and Dentistry,University of Ghana, Accra, Ghana, 2Department of Psychology, School of Medicine and Dentistry, Accra, Ghana, 3Department of Community Health, School of Medicine and Dentistry, Accra, Ghana, 4Department of Community Health, School of Medicine and Dentistry,University of Ghana, Accra, Ghana, 5Medicine, School of Medicine and Dentistry,University of Ghana, Accra, Ghana, 6School of Medicine and Dentistry,University of Ghana, Accra, Ghana, 7Department of Psychology, School of Medicine and Dentistry, University of Ghana, Accra, Ghana

    Background/Purpose: Low Ankle-brachial index (ABPI) < 0.9 demonstrating peripheral vascular disease (PVD), is a marker of subclinical cardiovascular disease and it is an inexpensive and…
  • Abstract Number: 1290 • 2018 ACR/ARHP Annual Meeting

    Systemic Inflammation and Atherosclerosis in Patients with Gout. Results from the NOR-Gout Study

    Silvia Rollefstad1, Till Uhlig2,3, Lars Fridtjof Karoliussen3, Hilde B. Hammer4 and Anne Grete Semb5, 1Preventive Cardio-Rheuma clinic, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2University of Oslo, Oslo, Norway, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Dept. of Rheumtology, Diakonhjemmet Hospital, Oslo, Norway, 5Preventive Cardio-Rheuma clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Systemic inflammation and atherosclerosis in patients with gout. Results from the NOR-Gout studyBackground/Purpose: The association between gout and cardiovascular disease (CVD) is well known, whereas…
  • Abstract Number: 1862 • 2018 ACR/ARHP Annual Meeting

    Exploring the Lipid Paradox Theory in Rheumatoid Arthritis: Very Low Circulating Low-Density Lipoprotein Concentration Levels Are Associated with Pro-Atherogenic Biomarkers

    Jon T. Giles1, Cecilia P. Chung2, Mary Chester-Wasko3, Mike Centola4, Jenny Van Eyk5, Justyna Fert-Bober5, Amy Kao6, Annette M. Oeser7, C. Michael Stein2 and Joan Bathon8, 1Medicine/Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 2Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 3Allegheny Health Network, Pittsburgh, PA, 4Haus Bioceuticals, Inc, Oklahoma City, OK, 5Cedars-Sinai Medical Center, Los Angeles, CA, 6Biogen, Cambridge, MA, 7Vanderbilt University Medical Center, Nashville, TN, 8Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY

    Background/Purpose: Rheumatoid arthritis (RA) patients with very low levels of circulating low density lipoprotein cholesterol (LDL-C) have been reported to be at particularly high risk…
  • Abstract Number: 2771 • 2018 ACR/ARHP Annual Meeting

    Current Practice of Cardiovascular Risk Assessment in Giant Cell Arteritis: A Single Center Study

    Mohammed Bari1, Anthony Ocon2, Mohamed Tageldin1, Mirrah Mumtaz1, Muhammad Saad Shaukat1, Paul Feustel1, Ruben Peredo2, Peter C. Grayson3 and Shubhasree Banerjee1,4,5, 1Albany Medical Center, Albany, NY, 2Medicine, Albany Medical Center, Albany, NY, 3National Institute of Arthritis, Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD, 4The Center for Rheumatology, Albany, NY, 5Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, MD

    Background/Purpose: Giant cell arteritis (GCA) is a large vessel vasculitis affecting individuals over 50 years of age. Multiple epidemiological studies have determined increased risk of…
  • Abstract Number: 503 • 2018 ACR/ARHP Annual Meeting

    Waist Circumference Based Abdominal Obesity Versus Body Mass Index in Rheumatoid Arthritis: Influence on the Risk of Diabetes and Cardiovascular Disease

    Gulsen Ozen1, Sofia Pedro2 and Kaleb Michaud1,2, 1Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS

    Background/Purpose: Adipose tissue deposited around the mesentery is highly associated with insulin resistance and cardiovascular disease (CVD). Compared to BMI, waist circumference (WC) has been…
  • Abstract Number: 777 • 2018 ACR/ARHP Annual Meeting

    Electrocardiographic Abnormalities Are Associated with the Occurrence of Strokes in Systemic Lupus Erythematosus

    Thania Perez1, Christopher Depender2, Jianhua Li3 and Laura Geraldino-Pardilla4, 1Columbia University, College of Physicians & Surgeons, New York, NY, 2Medicine/Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 3Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, 4Division of Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY

    Electrocardiographic Abnormalities Are Associated with the Occurrence of Strokes in Systemic Lupus Erythematosus  Background/Purpose: Systemic lupus erythematosus (SLE) patients have a 10-fold higher risk for…
  • Abstract Number: 1337 • 2018 ACR/ARHP Annual Meeting

    Myocardial Fatty Acid Metabolism and Perfusion Mismatch in Scintigraphy Predicts Worse Prognosis in Clinically Amyopathic Dermatomyositis

    Harunobu Iida1, Hironari Hanaoka1, Kana Ishimori2, Tomofumi Kiyokawa1, Yukiko Takakuwa1 and Kimito Kawahata1, 1Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 2Division of Rheumatology and Allergy, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan

    Background/Purpose: Clinically amyopathic dermatomyositis (CADM) patients are frequently manifested by rapidly progressive interstitial lung disease (ILD) and associated with a poor prognosis. Recently cardiac involvement…
  • Abstract Number: 1880 • 2018 ACR/ARHP Annual Meeting

    Cardiovascular (CV) Risk Factors and Atherosclerotic CV Events Among Incident Cases of Systemic Sclerosis: Results from a Population Based Cohort (1980-2016)

    Avneek Singh Sandhu1, Reto Kurmann2, Cynthia S. Crowson3, Rekha Mankad2, Eric L. Matteson4, Thomas Osborn1, Kenneth J. Warrington5 and Ashima Makol1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Cardiovascular Diseases, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 4Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 5Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN

    Background/Purpose: Cardiac involvement, due to impairment of coronary microcirculation and myocardial fibrosis, affects prognosis in individuals with SSc, and represents one of the leading causes…
  • Abstract Number: 2802 • 2018 ACR/ARHP Annual Meeting

    Risk of Ischemic Stroke in Veterans with Systemic Sclerosis: A Nationwide Cohort Study

    David Ying1,2, Milena Gianfrancesco1, Laura Trupin1, Jinoos Yazdany1, Eric Greidinger3,4 and Gabriela Schmajuk2,5, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2San Francisco VA Medical Center, San Francisco, CA, 3Medicine/Rheumatology, University of Miami Miller School of Medicine, Miami, FL, 4Miami VA Medical Center, Miami, FL, 5Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA

    Background/Purpose: Previously thought to involve primarily the microvasculature, systemic sclerosis (SSc) has been increasingly linked to macrovascular disease. Cardiovascular and cerebrovascular disease are responsible for…
  • Abstract Number: 504 • 2018 ACR/ARHP Annual Meeting

    Views of Primary Care Physicians and Rheumatologists Regarding Screening and Management of Hyperlipidemia Among Patients with Rheumatoid Arthritis

    Iris Navarro-Millán1,2, Anna Cornelius-Schecter2, Ronan O'Beirne3, Melanie Morris3, Susan Goodman1, Andrea Cherrington3, Liana Fraenkel4, Jeffrey R. Curtis3 and Monika M. Safford2, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY, 3University of Alabama at Birmingham, Birmingham, AL, 4Yale University, New Haven, CT

    Background/Purpose: Screening and management of hyperlipidemia in rheumatoid arthritis (RA) is suboptimal, despite RA patients’ high risk for cardiovascular disease (CVD) mortality. Our purpose was…
  • Abstract Number: 788 • 2018 ACR/ARHP Annual Meeting

    Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients with Systemic Sclerosis

    Susanne Van Wijngaarden1, Maaike Boonstra2, Bas Bloem3, Daniela Cassani4, Felix Tanner4, Suzana Jordan5, Oliver Distler6, Martin Jan Schalij3, V. Delgado1, J.J. Bax1, Jeska de Vries-Bouwstra7 and Nina Ajmone Marsan1, 1Heart and Lung Center, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Leiden University Medical Center, Leiden, Netherlands, 4University Heart Center, University Hospital Zurich, Zurich, Switzerland, 5Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 6Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 7Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Cardiac events are an important cause of mortality in Systemic Sclerosis (SSc), but its diagnosis remains challenging. Left ventricular global longitudinal strain is a…
  • Abstract Number: 1512 • 2018 ACR/ARHP Annual Meeting

    Reduction in Power Doppler Ultrasound Score with Tocilizumab Treatment Associates with Improvement in the Protective Profile of HDL in Patients with Rheumatoid Arthritis

    Christina Charles-Schoeman1, Gurjit Kaeley2, Jennifer Wang3, Ani Shahbazian3, Jenny Brook4, David Elashoff4 and Veena K. Ranganath5, 1Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, 2UF Health Jacksonville, Jacksonville, FL, 3University of California, Los Angeles, Los Angeles, CA, 4Department of Medicine Statistics Core, UCLA David Geffen School of Medicine, Los Angeles, CA, 51000 VETERAN BLVD., RM 32-59, UCLA, Los Angeles, CA

    Background/Purpose: Musculoskeletal ultrasound (MSUS) can detect synovitis by Power doppler (PDUS) and can predict erosive progression on xrays in rheumatoid arthritis (RA) patients. We previously…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology